BACE1, a rate-limiting enzyme involved in generating amyloid-β peptides (Aβ) in AD, is elevated due to the depletion of nuclear factor erythroid-derived 2, which represses the expression of BACE1 [42]. This evidence concerns the gene BACE1 and Alzheimer disease.